• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国和台湾地区接受治疗的阿片类药物依赖个体的死因及预期寿命损失年数。

Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.

作者信息

Chang Kun-Chia, Wang Jung-Der, Saxon Andrew, Matthews Abigail G, Woody George, Hser Yih-Ing

机构信息

Jianan Psychiatric Center, Taiwan; National Cheng Kung University, Taiwan.

National Cheng Kung University, Taiwan; National Cheng Kung University Hospital, Taiwan.

出版信息

Int J Drug Policy. 2017 May;43:1-6. doi: 10.1016/j.drugpo.2016.12.003. Epub 2017 Feb 1.

DOI:10.1016/j.drugpo.2016.12.003
PMID:28160734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5420493/
Abstract

AIMS

This study compared the cause-specific standardized mortality ratios (SMRs) and expected years of life lost (EYLL) among opioid-dependent individuals in the United States and Taiwan.

METHODS

Survival data came from two cohorts followed until 2014: The U.S. data were based on a randomized trial of 1267 opioid-dependent participants enrolled between 2006 and 2009; the Taiwan data were from a study of 983 individuals that began in 2006, when opioid agonist treatment (OAT) was implemented in Taiwan. SMRs were calculated for each national cohort and compared. Kaplan-Meier estimation was performed on the survival data, then lifespans were extrapolated to 70 years (840 months) to estimate life expectancy using a semi-parametric method. EYLLs for both cohorts were estimated by subtracting their life expectancies from the age- and gender-matched referents within the general population of their respective country.

RESULTS

Compared with age- and gender-matched referents, the SMRs were 3.2 for the U.S. sample and 7.8 for the Taiwan sample; the EYLLs were 7.7 and 16.4 years, respectively. Half of decedents died of unnatural causes in both cohorts; overdose deaths predominated in the U.S. and suicide in Taiwan.

CONCLUSIONS

Our study identified differences by country in EYLL and causes of deaths. These findings suggest that intervention strategies to reduce mortality risk by overdose (particularly in the U.S.) and suicide (particularly in Taiwan) are urgently needed in these countries.

摘要

目的

本研究比较了美国和台湾地区阿片类药物依赖者的特定病因标准化死亡率(SMR)和预期寿命损失年数(EYLL)。

方法

生存数据来自两个随访至2014年的队列:美国的数据基于2006年至2009年招募的1267名阿片类药物依赖参与者的随机试验;台湾的数据来自一项始于2006年的983人的研究,当时台湾开始实施阿片类激动剂治疗(OAT)。计算每个国家队列的SMR并进行比较。对生存数据进行Kaplan-Meier估计,然后使用半参数方法将寿命外推至70岁(840个月)以估计预期寿命。通过从各自国家一般人群中年龄和性别匹配的参照对象的预期寿命中减去两个队列的预期寿命来估计EYLL。

结果

与年龄和性别匹配的参照对象相比,美国样本的SMR为3.2,台湾样本的SMR为7.8;EYLL分别为7.7年和16.4年。两个队列中一半的死者死于非自然原因;美国以过量用药死亡为主,台湾以自杀为主。

结论

我们的研究确定了不同国家在EYLL和死亡原因方面的差异。这些发现表明,在这些国家迫切需要采取干预策略来降低过量用药(特别是在美国)和自杀(特别是在台湾)导致的死亡风险。

相似文献

1
Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.美国和台湾地区接受治疗的阿片类药物依赖个体的死因及预期寿命损失年数。
Int J Drug Policy. 2017 May;43:1-6. doi: 10.1016/j.drugpo.2016.12.003. Epub 2017 Feb 1.
2
Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.台湾阿片类药物替代治疗(OST)时代海洛因使用者的预期寿命及预期寿命损失年数估计。
Drug Alcohol Depend. 2015 Aug 1;153:152-8. doi: 10.1016/j.drugalcdep.2015.05.033. Epub 2015 May 28.
3
Causes of death in a cohort treated for opioid dependence between 1985 and 2005.1985 年至 2005 年间接受阿片类药物依赖治疗队列的死亡原因。
Addiction. 2014 Jan;109(1):90-9. doi: 10.1111/add.12337. Epub 2013 Oct 9.
4
Causes of Death After Nonfatal Opioid Overdose.非致死性阿片类药物过量后的死亡原因。
JAMA Psychiatry. 2018 Aug 1;75(8):820-827. doi: 10.1001/jamapsychiatry.2018.1471.
5
Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan.台湾主要精神疾病患者的超额死亡率和预期寿命缩短。
Epidemiol Psychiatr Sci. 2020 Aug 14;29:e156. doi: 10.1017/S2045796020000694.
6
The Burden of Opioid-Related Mortality in the United States.美国阿片类药物相关死亡率负担。
JAMA Netw Open. 2018 Jun 1;1(2):e180217. doi: 10.1001/jamanetworkopen.2018.0217.
7
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.在美国全州接受阿片类药物使用障碍服务的人群中,阿片类激动剂治疗与致命性药物过量风险的关系。
Addiction. 2020 Sep;115(9):1683-1694. doi: 10.1111/add.14991. Epub 2020 Feb 24.
8
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis.建模阿片类激动剂治疗对注射吸毒者多种死亡结局的干预效果:三设定分析。
Lancet Psychiatry. 2021 Apr;8(4):301-309. doi: 10.1016/S2215-0366(20)30538-1. Epub 2021 Feb 25.
9
Are we missing opioid-related deaths among people with HIV?我们是否遗漏了艾滋病毒感染者的阿片类药物相关死亡?
Drug Alcohol Depend. 2020 Jul 1;212:108003. doi: 10.1016/j.drugalcdep.2020.108003. Epub 2020 Apr 25.
10
Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada.美沙酮维持治疗与有犯罪记录人群的死亡率:来自加拿大的一项基于人群的回顾性队列研究。
PLoS Med. 2018 Jul 31;15(7):e1002625. doi: 10.1371/journal.pmed.1002625. eCollection 2018 Jul.

引用本文的文献

1
Association of substance use with suicide mortality: An updated systematic review and meta-analysis.物质使用与自杀死亡率的关联:一项更新的系统评价与荟萃分析。
Drug Alcohol Depend Rep. 2024 Dec 13;14:100310. doi: 10.1016/j.dadr.2024.100310. eCollection 2025 Mar.
2
Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment.美沙酮和丁丙诺啡维持治疗的海洛因依赖患者的生活质量及其相关因素。
Neuropsychopharmacol Rep. 2023 Dec;43(4):607-615. doi: 10.1002/npr2.12402. Epub 2023 Dec 13.
3
Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis.精神障碍患者的预期寿命和潜在寿命损失年数:一项系统评价和荟萃分析。
EClinicalMedicine. 2023 Oct 31;65:102294. doi: 10.1016/j.eclinm.2023.102294. eCollection 2023 Nov.
4
Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics.提供美国初级保健诊所中成瘾治疗的预估临床结果和成本效益分析。
JAMA Netw Open. 2023 Apr 3;6(4):e237888. doi: 10.1001/jamanetworkopen.2023.7888.
5
Characteristics and Weight Loss Practices From a Cohort of 20,000 Patients Using Direct-to-Consumer Telehealth: Observational Cross-sectional Study.一项对20000名使用直接面向消费者的远程医疗患者的队列研究:观察性横断面研究的特征及减肥实践
JMIR Form Res. 2023 Jan 5;7:e40062. doi: 10.2196/40062.
6
Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.注射吸毒相关性感染性心内膜炎患者的成瘾治疗和抗生素治疗策略的模拟成本效益及长期临床结局。
JAMA Netw Open. 2022 Feb 1;5(2):e220541. doi: 10.1001/jamanetworkopen.2022.0541.
7
Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.接受丁丙诺啡门诊治疗的患者的初级保健和药物管理特征。
Fam Pract. 2022 Mar 24;39(2):234-240. doi: 10.1093/fampra/cmab166.
8
Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study.基于医院的策略解决美国阿片类药物泛滥的临床影响、成本和成本效益:一项建模研究。
Lancet Public Health. 2022 Jan;7(1):e56-e64. doi: 10.1016/S2468-2667(21)00248-6. Epub 2021 Nov 30.
9
Pleasure, addiction, and hypocretin (orexin).愉悦、成瘾与下丘脑泌素(食欲素)。
Handb Clin Neurol. 2021;180:359-374. doi: 10.1016/B978-0-12-820107-7.00022-7.
10
Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France.法国某疼痛中心慢性非癌痛患者阿片类药物滥用和阿片类药物使用障碍与处方阿片类药物
Int J Environ Res Public Health. 2021 Feb 21;18(4):2097. doi: 10.3390/ijerph18042097.

本文引用的文献

1
President Obama Proposes $1.1 Billion in New Funding to Address the Prescription Opioid Abuse and Heroin Use Epidemic.奥巴马总统提议提供11亿美元新资金,以应对处方阿片类药物滥用和海洛因使用泛滥问题。
J Pain Palliat Care Pharmacother. 2016 Jun;30(2):134-7. doi: 10.3109/15360288.2016.1173760.
2
Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015.2001 - 2015年澳大利亚治疗结果研究队列中,海洛因使用者的潜在寿命损失年数。
Drug Alcohol Depend. 2016 May 1;162:206-10. doi: 10.1016/j.drugalcdep.2016.03.010. Epub 2016 Mar 18.
3
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.在一项多中心试验中,随机分配接受丁丙诺啡/纳洛酮与美沙酮治疗后的长期结果。
Addiction. 2016 Apr;111(4):695-705. doi: 10.1111/add.13238. Epub 2016 Jan 13.
4
Gender differences in mortality among treated opioid dependent patients.接受治疗的阿片类药物依赖患者的死亡率性别差异。
Drug Alcohol Depend. 2015 Oct 1;155:228-35. doi: 10.1016/j.drugalcdep.2015.07.010. Epub 2015 Jul 17.
5
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.国家和州对阿片类激动剂药物辅助治疗的需求及能力
Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.
6
Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.台湾阿片类药物替代治疗(OST)时代海洛因使用者的预期寿命及预期寿命损失年数估计。
Drug Alcohol Depend. 2015 Aug 1;153:152-8. doi: 10.1016/j.drugalcdep.2015.05.033. Epub 2015 May 28.
7
Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.2006 - 2010年加利福尼亚州接受阿片类药物依赖药物治疗的个体的死亡率。
Addiction. 2015 Jun;110(6):996-1005. doi: 10.1111/add.12863. Epub 2015 Mar 15.
8
Trends in opioid analgesic abuse and mortality in the United States.美国阿片类镇痛药滥用和死亡率的趋势。
N Engl J Med. 2015 Jan 15;372(3):241-8. doi: 10.1056/NEJMsa1406143.
9
Excessive suicide mortality and risk factors for suicide among patients with heroin dependence.海洛因依赖患者中过高的自杀死亡率及自杀风险因素。
Drug Alcohol Depend. 2014 Dec 1;145:224-30. doi: 10.1016/j.drugalcdep.2014.10.021. Epub 2014 Nov 3.
10
Medication-assisted therapies--tackling the opioid-overdose epidemic.药物辅助治疗——应对阿片类药物过量流行问题
N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23.